ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 279 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.89 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,002,000 | -23.4% | 300,000 | -45.5% | 0.15% | -26.2% |
| Q3 2021 | $9,136,000 | -60.2% | 550,000 | -41.5% | 0.20% | -67.4% |
| Q2 2021 | $22,927,000 | -18.7% | 940,000 | +78.2% | 0.62% | -32.3% |
| Q4 2020 | $28,205,000 | +87.0% | 527,600 | +47.8% | 0.92% | -56.0% |
| Q1 2020 | $15,083,000 | +552.9% | 357,000 | +561.1% | 2.08% | +43.1% |
| Q4 2019 | $2,310,000 | – | 54,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
| Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
| Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
| SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
| HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
| Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
| Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
| EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
| WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |